| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/24/2010 | WO2010071132A1 Peptide for inhibiting skin aging |
| 06/24/2010 | WO2010070877A1 Elovl7 epitope peptides and vaccines containing the same |
| 06/24/2010 | WO2010070394A1 Modulators of the cx3cr1 receptor and therapeutic uses thereof |
| 06/24/2010 | WO2010070253A1 Glucagon analogues |
| 06/24/2010 | WO2010070137A1 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
| 06/24/2010 | WO2010070136A2 Novel caviidae allergens and uses thereof |
| 06/24/2010 | WO2010070095A1 Method to select animals with a high capacity of embryo production |
| 06/24/2010 | WO2010070078A1 Anticancer compounds |
| 06/24/2010 | WO2010070047A1 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 06/24/2010 | WO2010069929A1 Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma. |
| 06/24/2010 | WO2010069605A2 Oxidized cardiolipin as a novel pro-inflammatory factor |
| 06/24/2010 | WO2010069570A2 Peptides against autoantibodies associated with crps and use of these peptides |
| 06/24/2010 | WO2010069331A2 Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders |
| 06/24/2010 | WO2010069204A1 Pluripotent stem cells, method for preparation thereof and uses thereof |
| 06/24/2010 | WO2010069090A2 Pharmaceutical composition containing angiotensin-(1-9) for cardiovascular, pulmonary and/or cerebral treatment |
| 06/24/2010 | WO2010069074A1 Membrane type-1 matrix metalloprotein inhibitors and uses thereof |
| 06/24/2010 | WO2010069060A1 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin |
| 06/24/2010 | WO2010049590A3 A new pharmaceutical product |
| 06/24/2010 | WO2010046588A9 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 06/24/2010 | WO2010046298A3 Improved peptide availability |
| 06/24/2010 | WO2010043972A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/24/2010 | WO2010043444A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/24/2010 | WO2010042942A3 Biochemically stabilized hiv-1 env trimer vaccine |
| 06/24/2010 | WO2010041827A3 NF-κB INHIBITOR CONTAINING ARH1 PROTEIN OR GENE ENCODING THE SAME |
| 06/24/2010 | WO2010038239A3 Pharmaceutical composition comprising coenzyme q10 |
| 06/24/2010 | WO2010034514A9 Novel regulators of the innate immune system |
| 06/24/2010 | WO2010030840A3 Novel receptor and uses thereof |
| 06/24/2010 | WO2010024557A3 Biopolymer conjugates comprising an interleukin-11 analog |
| 06/24/2010 | WO2010011952A3 Flip death effector domain derived peptides for inducing autophagy |
| 06/24/2010 | WO2010011600A3 Method for removal or inactivation of heparin |
| 06/24/2010 | WO2009151788A3 Universal anchor peptide for nanoparticles |
| 06/24/2010 | WO2009135615A3 Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t-cells |
| 06/24/2010 | WO2009108745A9 Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation |
| 06/24/2010 | WO2009089401A3 Compositions comprising toll-like receptor or coreceptor antagonists and methods for treating or controlling ocular allergy using same |
| 06/24/2010 | US20100162421 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 06/24/2010 | US20100162418 Recombinant protein s composition |
| 06/24/2010 | US20100160895 Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents |
| 06/24/2010 | US20100160894 Automatic injection device |
| 06/24/2010 | US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein |
| 06/24/2010 | US20100160611 Human skeletal muscle-specific ubiquitin-conjugating enzyme |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160241 Novel compound having gpr54 agonistic activity |
| 06/24/2010 | US20100160240 Treatment for epilepsy |
| 06/24/2010 | US20100160239 Peptide nucleic acid based guanidinium compounds |
| 06/24/2010 | US20100160238 TGFP-CAP Peptide and its Uses |
| 06/24/2010 | US20100160237 Dry feedstuff for controlling excess weight and obesity of dogs |
| 06/24/2010 | US20100160236 Method for Preventing Formation of Trisulfide Derivatives of Polypeptides |
| 06/24/2010 | US20100160235 Fgf homologs compositions and uses thereof |
| 06/24/2010 | US20100160234 Cell-proliferation inhibiting vpg proteins, fragments or analogs thereof and their applications |
| 06/24/2010 | US20100160233 Antitumour combinations containing a vegf inhibiting agent and irinotecan |
| 06/24/2010 | US20100160232 Physiologically active complex comprising protamine and/or salt thereof and an acidic macromolecular substance, and use thereof |
| 06/24/2010 | US20100160230 Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system |
| 06/24/2010 | US20100160229 Treatment of early-stage osteoarthritis |
| 06/24/2010 | US20100160228 Method for inhibiting or stimulating angiogenesis in an individual |
| 06/24/2010 | US20100160227 Signaling peptides |
| 06/24/2010 | US20100160226 Y-receptor agonists |
| 06/24/2010 | US20100160225 Lefty, lefty derivatives and uses thereof |
| 06/24/2010 | US20100160224 Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same |
| 06/24/2010 | US20100160223 Synergetic Effects of HGF and Antibacterial Treatment |
| 06/24/2010 | US20100160222 Treatment of Psoriasis through Down-Regulation of the EGF-Receptor with Topically Applied EGF |
| 06/24/2010 | US20100160221 Effect of tula on hiv |
| 06/24/2010 | US20100160220 Compositions and Methods for Improving Bone Mass Through Modulation of Novel Receptors of PTH and Fragments Thereof |
| 06/24/2010 | US20100160219 Novel Polypeptides Inducing Dendritic Cell Migration, as Well as Medicines and Pharmaceutical Compositions Containing Same |
| 06/24/2010 | US20100160218 Airway Administration of Tissue Factor Pathway Inhibitor in Inflammatory Conditions Affecting the Respiratory Tract |
| 06/24/2010 | US20100160217 Acetylycholine gated ion channel chaperons and methods of using the same |
| 06/24/2010 | US20100160216 Enhanced transport using membrane disruptive agents |
| 06/24/2010 | US20100160215 Antibiotic compositions for the treatment of gram negative infections |
| 06/24/2010 | US20100160214 Desmopressin composition |
| 06/24/2010 | US20100160213 Antimicrobial and anticancer lipopeptides |
| 06/24/2010 | US20100160212 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 06/24/2010 | US20100160211 Glycopeptide phosphonate derivatives |
| 06/24/2010 | US20100160210 Guanidinium delivery carriers |
| 06/24/2010 | US20100160209 Composition and Method for Increasing Cell Permeability of a Compound |
| 06/24/2010 | US20100160208 Pharmaceutical composition |
| 06/24/2010 | US20100160207 Feedback Prodrug |
| 06/24/2010 | US20100160175 Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds |
| 06/24/2010 | US20100160174 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 06/24/2010 | US20100159563 Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100159439 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 06/24/2010 | US20100159032 Combinations useful for the treatment of neuronal disorders |
| 06/24/2010 | US20100159030 Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating turmorgenicity |
| 06/24/2010 | US20100159017 Composition of biocompatible microparticles of alginic acid for the controlled release of active ingredients by intravenous administration |
| 06/24/2010 | US20100159014 Polymeric micellar clusters and their uses in formulating drugs |
| 06/24/2010 | US20100159011 Compositions For Biomedical Applications |
| 06/24/2010 | US20100159006 Improved antimicrobial peptides |
| 06/24/2010 | US20100159004 Methods and compositions for reduction of side effects of therapeutic treatments |
| 06/24/2010 | US20100159002 Dosage form comprising therapeutic formulation |
| 06/24/2010 | US20100158996 Ester compound and medical use thereof |
| 06/24/2010 | US20100158995 Systems for delivery and release of angiotensin-(1-7) |
| 06/24/2010 | US20100158994 Nanoparticles for Delivery of Therapeutic Agents Using Ultrasound and Associated Methods |
| 06/24/2010 | US20100158979 Temporal release of growth factors from 3d micro rod scaffolds for tissue regeneration |
| 06/24/2010 | US20100158976 Collagen/hydroxyapatite composite scaffold, and process for the production thereof |
| 06/24/2010 | US20100158975 Extracellular matrix compositions |
| 06/24/2010 | US20100158972 Method for reducing the likelihood of preterm labor in a subject in need thereof |
| 06/24/2010 | US20100158971 Method for reducing the likelihood of preeclampsia in a subject in need thereof |
| 06/24/2010 | US20100158969 Flexible implantable composites and implants comprising same |
| 06/24/2010 | US20100158968 Cell-permeant peptide-based inhibitor of kinases |
| 06/24/2010 | US20100158956 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |